| Primary | Biochemically Confirmed Smoking Abstinence Sustained for 6 Months | The primary outcome measure is sustained abstinence for 6 months, and will require self-report of smoking cessation followed by biochemical confirmation at 2 weeks, 3, and 6 months. | Seven participants passed away prior to their quit ate assessment. One participant passed away after their 2-week lab assessment. | Posted | | Count of Participants | | Participants | | 6 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. | | OG003 | Enhanced Usual Care Plus Financial Incentives Plus Mobile Health Application | Participants receive all aspects of Arm 3 plus an intervention to promote episodic future thinking (EFT), called FutureMe. EFT has been shown to reliably reduce discounting of the future. Patients will practice using EFT cues to envision the "future is now" between the time of enrollment and the quit date, and will then receive cues from the quit date through the end of the intervention period, 6 months later, unless they ask to stop receiving cues sooner. |
| | Units | Counts |
|---|
| Participants | - OG000605
- OG001883
- OG002888
- OG003
|
| | Title | Denominators | Categories |
|---|
| | | Title | Measurements |
|---|
| - OG00026
- OG00145
- OG00278
- OG003
|
|
| | Group IDs | Group Description | Statistical Method | Statistical Comment | P-Value | P-Value Comment | Parameter Type | Parameter Value | Dispersion Type | Dispersion Value | Confidence Interval Sides | Confidence Interval % | CI Lower Limit | CI Upper Limit | CI Lower Limit Comment | CI Upper Limit Comment | Estimate Comment | Tested Non-Inferiority | Non-Inferiority Type | Non-Inferiority Comment | Other Analysis Description |
|---|
| | Regression, Logistic | | 0.797 | | Risk Difference (RD) | 0.00 | | | 2-Sided | 95 | -0.02 | 0.02 | | | | | Superiority | | | | | Regression, Logistic | | 0.001 |
|
| Secondary | Quit Status (Biochemically Confirmed) | Rates of sustained biochemically confirmed smoking cessation | Seven participants passed away prior to their quit date assessment. One participant passed away after their 2-week lab assessment. | Posted | | Count of Participants | | Participants | | 2 weeks, 3 months, 12 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|
| Secondary | Health-related Quality of Life | The EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health. | | Posted | | Mean | Standard Deviation | score on a scale | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | |
|
| Secondary | Perceived Barriers to Cessation | The Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge. | | Posted | | Mean | Standard Deviation | score on a scale | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 |
|
| Secondary | Self-efficacy Related to Cessation Efforts | We will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy. | | Posted | | Mean | Standard Deviation | score on a scale | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|
| Secondary | Motivation to Quit | The Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit. | | Posted | | Count of Participants | | Participants | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|
| Secondary | Temporal ("Delay") Discounting | Temporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus & Bickel 2014. | | Posted | | Mean | Standard Deviation | k value | | Baseline | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives |
|
| Secondary | Health-related Quality of Life | The EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health. | | Posted | | Mean | Standard Deviation | score on a scale | | 6 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | |
|
| Secondary | Perceived Barriers to Cessation | The Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge. | | Posted | | Mean | Standard Deviation | score on a scale | | 6 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 |
|
| Secondary | Self-efficacy Related to Cessation Efforts | We will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy. | | Posted | | Mean | Standard Deviation | score on a scale | | 6 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|
| Secondary | Motivation to Quit | The Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit. | | Posted | | Count of Participants | | Participants | | 6 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|
| Secondary | Temporal ("Delay") Discounting | Temporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus & Bickel 2014. | | Posted | | Mean | Standard Deviation | k value | | 6 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives |
|
| Secondary | Health-related Quality of Life | The EuroQuol Group's quality of life (EQ-5D-5L) scale is a 25-item validated scale used to assess patients' perceived health-related quality of life across the domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Scale range: -1 to 1 index calculated from SAS package provided by author. Additionally calculating misery score which is sum of scores ranging from 5 to 25. For index, 1 is best possible health, while -1 are states worse than death. For the misery score, higher is worse health. | | Posted | | Mean | Standard Deviation | score on a scale | | 12 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | |
|
| Secondary | Perceived Barriers to Cessation | The Challenges to Stopping Smoking Scale (CSS-21) is a validated 21-item measure to assess patients' perceived barriers to smoking cessation. The CSS-21 has two sub-scales: intrinsic factors (physical, psychological or cognitive aspects of quitting), 9 item intrinsic factors scale from 9-36, and extrinsic factors (social or environmental aspects of quitting), 12 item extrinsic factors scale from 12-43. Total score was also prepared, range 21-79. A higher score means a greater challenge. | | Posted | | Mean | Standard Deviation | score on a scale | | 12 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 |
|
| Secondary | Self-efficacy Related to Cessation Efforts | We will use the 10-item situational measure of self-efficacy related to smoking behavior. This scale measures how sure participants are that they can avoid smoking in different situations. The scale ranges from 10-40, with a higher score demonstrating more self-efficacy. | | Posted | | Mean | Standard Deviation | score on a scale | | 12 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|
| Secondary | Motivation to Quit | The Stages of Change (SOC) is a validated 1-item measure to assess patient's self-reported motivation to quit. | | Posted | | Count of Participants | | Participants | | 12 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|
| Secondary | Temporal ("Delay") Discounting | Temporal discounting is a measure of impulsivity that reflects people's tendencies to discount the value of a reward as a function of how far in the future it would be received. We will use the 5-Trial Adjusting Delay Task to assess temporal discounting. The scale ranges from 0.000110 to 24, with a higher value meaning present is valued more over future gain. K values were calculated in R using the values noted in Koffarnus & Bickel 2014. | | Posted | | Mean | Standard Deviation | k value | | 12 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives |
|
| Secondary | Self-report Cigarette Abstinence | Rates of sustained self-reported cigarette abstinence | Seven participants passed away before their quit date assessment. One participant passed away after their 2 week lab assessment. | Posted | | Count of Participants | | Participants | | 2 weeks, 3 months, 6 months, 12 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|
| Secondary | Self-report Other Tobacco Abstinence | Rates of sustained self-reported other tobacco abstinence | Seven participants passed away before their quit date assessment. One participant passed away after their 2-week lab assessment. | Posted | | Count of Participants | | Participants | | 2 weeks, 3 months, 6 months, 12 months | | | | ID | Title | Description |
|---|
| OG000 | Basic Usual Care | Participants receive the usual care approach, Ask-Advise-Refer (AAR), which is a standard approach in which non-study clinicians ask smokers about their desire to quit smoking, advise them to quit, and provide informational resources such as hotlines, specialized clinics, or smoking cessation classes. | | OG001 | Enhanced Usual Care | Participants receive the basic usual care of Ask-Advise-Refer as well as free access to nicotine replacement therapy (NRT) and/or reimbursement of up to $300 for any smoking cessation medications (varenicline/Chantix or bupropion/Zyban) prescribed by non-study clinicians. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications | | OG002 | Enhanced Usual Care Plus Financial Incentives | Participants receive all aspects of enhanced usual care plus an incentive plan in which they will be informed of their eligibility to earn $100, $200, and $300 if they submit negative tests for nicotine metabolites at 2 weeks, 3 month and 6 months following their quit date, respectively. Removal of Financial Barriers: Free access to nicotine replacement therapies and/or reimbursement for smoking cessation prescription medications Financial Incentives: Financial incentive plan of up to $600 for biochemically-confirmed, sustained abstinence for 6 months. |
|